These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8936709)

  • 1. In search of predictors of hypnotic sequelae.
    Page RA; Handley GW
    Am J Clin Hypn; 1996 Oct; 39(2):93-6. PubMed ID: 8936709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preventive measures in reducing aftereffects to hypnosis.
    Page RA; Handley GW
    Am J Clin Hypn; 1993 Jul; 36(1):26-37. PubMed ID: 8368193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting hypnotic susceptibility via a phenomenological approach.
    Forbes EJ; Pekala RJ
    Psychol Rep; 1993 Dec; 73(3 Pt 2):1251-6. PubMed ID: 8115579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of the Dissociative Experiences Scale: II. Its relationship to hypnotizability.
    Frischholz EJ; Braun BG; Sachs RG; Schwartz DR; Lewis J; Shaeffer D; Westergaard C; Pasquotto J
    Am J Clin Hypn; 1992 Oct; 35(2):145-52. PubMed ID: 1442646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenomenological experiences associated with hypnotic susceptibility.
    Varga K; Józsa E; Bányai EI; Gösi-Greguss AC; Kumar VK
    Int J Clin Exp Hypn; 2001 Jan; 49(1):19-29. PubMed ID: 11190789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portuguese norms for the harvard group scale of hypnotic susceptibility, form a.
    Carvalho C
    Int J Clin Exp Hypn; 2013; 61(2):219-31. PubMed ID: 23427845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian norms for the Stanford Hypnotic Susceptibility Scale, Form C.
    De Pascalis V; Bellusci A; Russo PM
    Int J Clin Exp Hypn; 2000 Jul; 48(3):315-23. PubMed ID: 10902296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portuguese norms for the Waterloo-Stanford Group C (WSGC) scale of hypnotic susceptibility.
    Carvalho C; Kirsch I; Mazzoni G; Leal I
    Int J Clin Exp Hypn; 2008 Jul; 56(3):295-305. PubMed ID: 18569140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and subjective scoring of the Harvard Group Scale of Hypnotic Susceptibility: further data and an extension.
    Kumar VK; Marcano G; Pekala RJ
    Am J Clin Hypn; 1996 Jan; 38(3):191-9. PubMed ID: 8712162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnotic responsivity of the deaf: the development of the University of Tennessee Hypnotic Susceptibility Scale for the Deaf.
    Repka RJ; Nash MR
    Int J Clin Exp Hypn; 1995 Jul; 43(3):316-31. PubMed ID: 7635582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Harvard Group Scale of Hypnotic Susceptibility and related instruments: individual and group administrations.
    Angelini FJ; Kumar VK; Chandler L
    Int J Clin Exp Hypn; 1999 Jul; 47(3):236-50. PubMed ID: 10616257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norms for the Korean version of the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Pyun YD; Kim YJ
    Int J Clin Exp Hypn; 2009 Jan; 57(1):117-26. PubMed ID: 19031236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imagery and hypnotizability revisited.
    Kogon MM; Jasiukaitis P; Berardi A; Gupta M; Kosslyn SM; Spiegel D
    Int J Clin Exp Hypn; 1998 Oct; 46(4):363-70. PubMed ID: 9780527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypnotic susceptibility scales: are the mean scores increasing?
    Benham G; Smith N; Nash MR
    Int J Clin Exp Hypn; 2002 Jan; 50(1):5-16. PubMed ID: 11778707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypnotizability and somatic complaints: a gender-specific phenomenon.
    Younger JW; Rossetti GC; Borckardt JJ; Smith AR; Tasso AF; Nash MR
    Int J Clin Exp Hypn; 2007 Jan; 55(1):1-13. PubMed ID: 17135060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariate approach to the prediction of hypnotic susceptibility.
    Dixon M; Labelle L; Laurence JR
    Int J Clin Exp Hypn; 1996 Jul; 44(3):250-64. PubMed ID: 8690536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuations in hypnotic susceptibility and imaging ability over a 16-hour period.
    Wallace B; Kokoszka A
    Int J Clin Exp Hypn; 1995 Jan; 43(1):20-33. PubMed ID: 7875918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypnotizability and absorption in a Danish sample: testing the influence of context.
    Zachariae R; Jørgensen MM; Christensen S
    Int J Clin Exp Hypn; 2000 Jul; 48(3):306-14. PubMed ID: 10902295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexican norms for the Stanford Hypnotic Susceptibility Scale, Form C.
    Sánchez-Armáss O; Barabasz AF
    Int J Clin Exp Hypn; 2005 Jul; 53(3):321-31. PubMed ID: 16076668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypnotic suggestibility, cognitive inhibition, and dissociation.
    Dienes Z; Brown E; Hutton S; Kirsch I; Mazzoni G; Wright DB
    Conscious Cogn; 2009 Dec; 18(4):837-47. PubMed ID: 19709904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.